# What Courts Have Ruled So Far in Lawsuits Over Insurers' Claim Algorithms

> Courts let contract and fair-housing claims over insurers' claim algorithms proceed, while Medicare preemption knocked out most state-law claims.

- Source: https://insureaiwire.com/insurance-ai-claims-lawsuits/
- Publication: InsureAI Wire
- Author: Simon Li
- Updated: 2026-11-19

---
UnitedHealth's [Medicare Advantage](/glossary/medicare-advantage/) plan documents, as the enrollees' complaint quotes them, say that its "Clinical Services Staff and Physicians" make decisions on the care an enrollee receives.[^1] Enrollees who say an algorithm called nH Predict made those decisions instead sued UnitedHealth in federal court in Minnesota. In February 2025 the court dismissed most of their claims as displaced by federal Medicare law.[^2] It let the rest go forward on a narrower question: whether UnitedHealth complied with its own written documents when it allegedly used artificial intelligence.[^2]

That suit is [Estate of Gene B. Lokken v. UnitedHealth Group](/unitedhealth-ai-governance/). As far as we found, three other suits over an insurer's claim algorithm have reached a ruling on whether their claims may go forward.[^3] They are a second Medicare Advantage suit over the same tool, against Humana, and suits against Cigna over employer plans' claims and against State Farm over homeowners' claims. In the three health cases, the claims that went forward rest mainly on what the plan documents say about who makes coverage decisions. In both Medicare Advantage cases, most other claims, including bad faith, were dismissed on the same federal ground. In the State Farm case a fair-housing claim went forward on a different theory: the allegation that the insurer's claim tools treated Black policyholders' claims worse than white policyholders'.

## Four suits and what they allege

The other Medicare Advantage case is Estate of Joanne Barrows v. Humana, in which the federal court for the Western District of Kentucky ruled in August 2025.[^4] Both it and Lokken allege that the insurer used nH Predict in place of physicians' judgment to cut short post-acute care after a hospital stay.[^5] The tool is run by naviHealth.[^6] In Lokken, naviHealth is a defendant alongside the UnitedHealth companies, and the Barrows opinion, quoting the complaint, calls it Humana's "contractor."[^5] The Lokken plaintiffs say the tool estimates a patient's care needs from similar patients. The Barrows plaintiffs say Humana's staff were disciplined for departing from the tool's predictions.[^5]

Cigna is sued over employer health plans governed by ERISA, for which it administers claims. In that case, Kisting-Leung v. Cigna, the federal court for the Eastern District of California ruled on March 31, 2025.[^7] The plaintiffs allege that Cigna's PxDx algorithm let its doctors deny payment in batches for treatments that did not match preset criteria, spending an average of 1.2 seconds on each request.[^7]

The one homeowners case is Huskey v. State Farm, brought by two Black homeowners and ruled on in September 2023 in the Northern District of Illinois.[^8] They allege that State Farm's algorithmic tools, used since at least 2018 to predict fraud and flag claims for scrutiny, slowed and questioned Black policyholders' claims more than white policyholders'.[^8]

## What a ruling on a motion to dismiss decides

Each ruling answered a motion to dismiss, a defendant's request to end a claim before evidence is exchanged. At that stage a court takes the factual allegations as true and asks only whether the law bars a claim and whether the facts alleged, if proven, would make one out.[^9] None of the rulings, then, found that nH Predict was used to deny care, was inaccurate or replaced physicians, and none made such a finding about PxDx or State Farm's tools. In Lokken the defendants, the UnitedHealth companies and naviHealth together, said in their reply brief that they "den[y] any use of nH Predict," the court's opinion records.[^10] Whether the tool has any role in their coverage determinations is the point no ruling has yet resolved.

## Why contract claims survived federal preemption

In Lokken and Barrows, the two Medicare Advantage cases, each court had to deal with exhaustion before it reached preemption. A claim arising under the Medicare Act generally must go through Medicare's administrative appeals before a court hears it, and no plaintiff in either case had finished them.[^11] Taking the allegations as true, both courts waived that requirement for irreparable harm and futility. Futility rested on alleged appeal tactics, such as issuing a new denial whenever a patient wins an appeal.[^12]

The Medicare Act's preemption clause says the federal standards for Medicare Advantage "shall supersede any State law or regulation (other than State licensing laws or State laws relating to plan solvency)" with respect to Medicare Advantage plans.[^13] Both courts held that this [federal preemption](/glossary/federal-preemption/) clause can reach common-law claims as well as statutes, the Lokken court adding "when appropriate."[^14] Its test was whether a claim regulates the same subject matter as a Medicare standard or frustrates its purpose.[^14]

Those standards govern how a plan decides: it must base a [medical necessity](/glossary/medical-necessity/) decision on, among other things, the enrollee's medical history, physician recommendations and clinical notes.[^15] Before it issues a decision it expects to be adverse on medical necessity, a physician or other appropriate health care professional must review it.[^16]

CMS, the federal agency that runs Medicare, has applied these standards to algorithms itself. A February 2024 memo on its 2023 Medicare Advantage rule says that an algorithm may assist a coverage decision, but the decision must still comply with the medical-necessity rule.[^17] A predicted length of stay, the memo adds, cannot alone justify ending post-acute care.[^17] Neither court cited the memo; both rested their reasoning on the regulations themselves.[^18]

On the reading of these two district courts, that is why the claims asking a court to judge the decisions fell. In Lokken, bad faith would have required the court to decide whether each denial, and the use of nH Predict to make it, was reasonable. The three state statutes, from Oregon, Minnesota and California, require reasonable standards for prompt, individualized evaluation of claims. Both kinds of claim, the Lokken court held, regulate what the federal standards already regulate, and so does unjust enrichment, which depends on which services are covered.[^19] All five counts were dismissed with prejudice.[^20]

In Barrows the plaintiffs conceded at the hearing that three state-law counts were preempted, including insurance bad faith and North Carolina's [unfair claims settlement](/glossary/unfair-claims-settlement-practices-act/) statute.[^21] A fourth count, under North Carolina's unfair competition statute, rested on the plaintiffs' claim that Humana violated that statute by delegating claim evaluation to nH Predict. The court held it preempted because federal standards govern how claim decisions are made. All four were dismissed with prejudice.[^22]

The contract claims rest on the Evidence of Coverage, the coverage document a Medicare Advantage insurer gives its enrollees. In Lokken, the plaintiffs allege that UnitedHealth described claim decisions as made by clinical staff and physicians, with no mention of artificial intelligence. Deciding that claim, the Lokken court said, requires only investigating whether UnitedHealth complied with its own written documents under basic contract principles, a subject the Medicare standards do not regulate.[^23] In a 2025 order the Lokken court held the claims to that question, confining them to breaches of Evidence of Coverage terms.[^24]

The Barrows court held the Evidence of Coverage to be part of the contract. The question, it said, is not whether the Medicare Act prohibits using AI in coverage decisions but whether the insurer's use of AI violates its contract.[^25] Unlike the Lokken court, it also let unjust enrichment proceed, because as pleaded the claim required only interpreting the Evidence of Coverage.[^26] It kept a claim of fraud by omission as well. The plaintiffs' theory is that the contract did not disclose that AI makes coverage determinations, so they paid premiums they would not otherwise have paid. The court held that the claim asks only whether Humana misled insureds in its own contract, and so is not preempted.[^27]

## The medical-director clause in an employer plan

A claim for breach of fiduciary duty under ERISA carried the algorithm theory in Kisting-Leung. Every plaintiff's benefits claim failed because none identified plan terms entitling them to the benefits; the court allowed an amended complaint, and the plaintiffs chose not to file one.[^28] The fiduciary claim instead challenged Cigna's process for deciding claims and sought an injunction against it, relief the court held distinct from paying benefits.[^29] The plaintiffs allege that their plans require a medical director to make medical-necessity decisions. The court assumed, without deciding, that the most deferential standard of review applied, which gives the administrator's reading of its plan the most room. Even so, it held that reading the plan to let an algorithm decide "so long as a medical director pushes the button" conflicts with the plan's plain language.[^29]

ERISA generally displaces state-law claims that relate to an employee benefit plan, including claims over how benefit claims are processed. A claim of that kind can proceed through ERISA's savings clause, which keeps state laws that regulate insurance.[^30] California Health and Safety Code § 1367.01(e) lets only a licensed physician, or a licensed health professional competent in the clinical issues involved, deny or modify an authorization request for lack of medical necessity. Alleging that PxDx made such denials instead, the plaintiffs sued under California's unfair competition law. The court held that the California statute regulates insurance, so the savings clause applies, and the claim went forward for two plaintiffs.[^31]

Standing for those two claims was the one question in the four rulings decided on evidence rather than on the allegations. What decided it was a Cigna declaration that three plaintiffs' claims were not denied through PxDx review. A PxDx denial, the declaration said, generates its own letter to the patient and provider. The plaintiffs called the declaration speculative but offered no contrary evidence, and the court dismissed the three from both claims for lack of standing.[^32] It gave them leave to amend; the plaintiffs told the court they would not amend, so those claims did not return.[^32]

## A homeowners claim about outcomes by race

Huskey rests on § 3604(b) of the Fair Housing Act, which bars race discrimination in services connected with the sale of a dwelling. The court held that homeowners insurance is such a service, including claim handling after the buyer moves in. It noted that the Seventh Circuit has not applied § 3604(b) to claims processing and that the plaintiffs are testing the Fair Housing Act's boundaries.[^33]

The claim is one of [disparate impact](/glossary/disparate-impact/): it alleges no intent, only that a policy fell harder on Black policyholders. It needs a statistical disparity, a specific policy and a causal link, and at the pleading stage the disparity need only be plausible rather than airtight. For an insurer, the holding that matters is on the policy. The court accepted State Farm's decision to use algorithmic decision-making tools to automate claims processing as that policy, without requiring the plaintiffs to define the policy more precisely at this stage.[^34] State Farm has said that if the plaintiffs make a prima facie showing, it will offer a business justification, the next step of a [disparate-impact test](/how-disparate-impact-shapes-ai-pricing/).[^35]

**Table [row-headers]:** Claim by claim, the four rulings on motions to dismiss

| Case | Went forward | Dismissed |
|---|---|---|
| Lokken (Medicare Advantage; D. Minn., February 2025)[^1] | Breach of contract; implied covenant of good faith and fair dealing | Unjust enrichment; insurance bad faith; Oregon negligence per se; Minnesota and California statutory claims. All with prejudice[^20] |
| Barrows (Medicare Advantage; W.D. Ky., August 2025)[^4] | Breach of contract; implied covenant; unjust enrichment; common-law fraud by omission | North Carolina unfair claims settlement and unfair-competition claims; insurance bad faith; unfair and deceptive insurance practices. All with prejudice, three of them conceded |
| Kisting-Leung (ERISA plans; E.D. Cal., March 2025)[^7] | ERISA fiduciary duty, for three plaintiffs; California unfair competition law, for two | ERISA benefits claim, for all plaintiffs, with leave to amend that was not used; the other plaintiffs' fiduciary and California claims, on standing or timeliness |
| Huskey (homeowners; N.D. Ill., September 2023)[^8] | Fair Housing Act § 3604(b), disparate impact | § 3604(a) and § 3605, without prejudice; [McCarran-Ferguson](/glossary/mccarran-ferguson-act/) defense rejected for now[^36] |

## What the plaintiffs may see of the algorithm

The surviving claims in Lokken are contract claims. Discovery, the exchange of documents relevant to the claims still in a case, is measured against them, and the March 2026 discovery order shows what that framing let in and what it kept out.[^37] It ordered documents on how nH Predict works, whether it was designed to supplant physician decision-making, who developed it, and its oversight by what the order calls UnitedHealth's AI Review Board.[^38] It refused the tool's data, rules, source code and underlying medical guidelines as not relevant to contract claims.[^39] The order also reached documents on government or regulatory investigations of UnitedHealth's use of nH Predict or other AI tools in post-acute claims.[^40] It treated whether nH Predict is used in making coverage determinations as a question for the merits.[^41]

## Where the cases go next

All four are proposed class actions, so class certification, the ruling on whether the named plaintiffs may sue for the whole group, comes next. In Barrows the plaintiffs propose a class defined by enrollment in certain Humana Medicare Advantage plans, whether or not members used post-acute care, which fits a contract claim about what the premiums paid for.[^42]

**Status as of November 17, 2026.** None of the four has a ruling on class certification or on the merits, and we found no reported settlement.[^43] The plaintiffs' class motion in Lokken is due February 16, 2027.[^44] In Barrows the plaintiffs filed theirs on November 5, 2026, and Humana's response is due February 19, 2027.[^44] The Kisting-Leung class motion is set for hearing on April 5, 2027.[^44] Huskey is in discovery.[^45] A motion in Barrows to add naviHealth as a defendant is still undecided.[^46][^47]

## Which records answer the questions the courts asked

On our reading, the contract and fiduciary claims compare an alleged practice with the coverage or plan wording, so the comparison mainly starts from that document. Standing in Kisting-Leung depended on whether a tool touched a plaintiff's claim. A [record kept for each AI-assisted decision](/insurance-ai-decision-evidence-pack/) would show that. Oversight records, which an [AI governance program](/ai-governance-in-insurance/) keeps, are among what the Lokken court ordered produced in a contract case. Proof in a disparate-impact case would rest on claim outcomes by race and on the insurer's own account of why it uses the tools.

[^1]: Memorandum Opinion and Order Granting in Part and Denying in Part Defendants' Motion to Dismiss, *Estate of Gene B. Lokken et al. v. UnitedHealth Group, Inc. et al.*, No. 23-3514 (JRT/DJF) (D. Minn. Feb. 13, 2025), Doc. 91, p. 3, quoting the amended complaint: https://litigationtracker.law.georgetown.edu/wp-content/uploads/2023/11/Lokken_2025.02.13_MEMORANDUM-OPINION-AND-ORDER.pdf
[^2]: Lokken opinion (note 1), pp. 19 and 24.
[^3]: Another suit over PxDx, *Snyder et al. v. Cigna Group*, No. 3:23-cv-01451 (D. Conn.), had no ruling on the motion to dismiss (ECF 61) as of the docket entry of November 4, 2026: https://www.courtlistener.com/docket/67940486/snyder-v-cigna-group/
[^4]: Memorandum Opinion and Order, *Estate of Joanne Barrows et al. v. Humana, Inc.*, No. 3:23-cv-654-RGJ (W.D. Ky.), Doc. 82, signed August 14 and entered August 15, 2025: https://litigationtracker.law.georgetown.edu/wp-content/uploads/2023/12/Barrows-et-al_2025.08.15_MEMORANDUM-OPINION-ORDER.pdf
[^5]: Lokken opinion (note 1), pp. 1 to 2 (parties) and 4 (allegations); Barrows opinion (note 4), pp. 2 (allegations) and 3 (naviHealth, quoting the complaint).
[^6]: Order on Plaintiffs' Motion to Compel, *Lokken* (D. Minn. Mar. 9, 2026), Doc. 162, p. 6 (naviHealth's use of nH Predict): https://litigationtracker.law.georgetown.edu/wp-content/uploads/2023/11/Estate-of-Gene-B.-Lokken-et-al-v.-UnitedHealth-Group-Inc.-et-al_2026_3_9_ORDER-ON-MOTION-TO-COMPEL-DISCOVERY.pdf
[^7]: Order Granting in Part and Denying in Part Defendants' Motion to Dismiss, *Kisting-Leung et al. v. Cigna Corp. et al.*, No. 2:23-cv-01477-DAD-CSK (E.D. Cal. Mar. 31, 2025), Doc. 55, p. 2, summarizing the complaint: https://litigationtracker.law.georgetown.edu/wp-content/uploads/2023/08/Kisting-Leung-et-al_2025.03.31_ORDER-GRANTING-IN-PART-AND-DENYING-IN-PART-DEFENDANTS-MOTION-TO-DISMISS.pdf
[^8]: Memorandum Opinion and Order, *Huskey and Wynn v. State Farm Fire & Casualty Co.*, No. 22 C 7014 (N.D. Ill. Sept. 11, 2023), Dkt. 52, pp. 1 and 3 to 5, summarizing the amended complaint, which cites a 2021 survey of about 800 Midwestern State Farm policyholders for the disparity. Copy at the Civil Rights Litigation Clearinghouse: https://clearinghouse-umich-production.s3.amazonaws.com/media/doc/139775.pdf
[^9]: Lokken opinion (note 1), pp. 6 to 7; Barrows opinion (note 4), pp. 5 to 6.
[^10]: Lokken opinion (note 1), p. 4.
[^11]: Barrows opinion (note 4), pp. 8 and 13 to 18, on 42 U.S.C. § 405(g) and (h); Lokken opinion (note 1), pp. 9 to 13. In Lokken no plaintiff had received a final decision from the Medicare Appeals Council.
[^12]: Lokken opinion (note 1), pp. 11 to 12; Barrows opinion (note 4), pp. 16 to 18; the two courts reached the waiver by different routes (Lokken, pp. 9 to 10; Barrows, pp. 9 to 13).
[^13]: 42 U.S.C. § 1395w-26(b)(3): https://www.law.cornell.edu/uscode/text/42/1395w-26. Lokken quotes it at p. 14, Barrows at p. 19.
[^14]: Lokken opinion (note 1), pp. 16 and 18; Barrows opinion (note 4), pp. 19 and 22.
[^15]: 42 C.F.R. § 422.101(c)(1)(i): https://www.ecfr.gov/api/renderer/v1/content/enhanced/current/title-42?part=422&section=422.101. Lokken cites the section at pp. 19 to 22.
[^16]: 42 C.F.R. § 422.566(d): https://www.ecfr.gov/api/renderer/v1/content/enhanced/current/title-42?part=422&section=422.566. The reviewer need not in all cases share the treating physician's specialty.
[^17]: CMS memo to Medicare Advantage organizations and Medicare-Medicaid plans, "Frequently Asked Questions related to Coverage Criteria and Utilization Management Requirements in CMS Final Rule (CMS-4201-F)," February 6, 2024, pp. 2 and 7 (questions 2 and 7). The rule was issued April 5, 2023. Copy published by the AAMC: https://www.aamc.org/media/74896/download?attachment
[^18]: Lokken opinion (note 1), pp. 19 to 22; Barrows opinion (note 4), pp. 25 to 26. Both cite 42 C.F.R. §§ 422.101, 422.566 and 422.568.
[^19]: Lokken opinion (note 1), pp. 19 to 21.
[^20]: Lokken opinion (note 1), p. 24. The Oregon count is pleaded as negligence per se.
[^21]: Barrows opinion (note 4), p. 4. The third conceded count was unfair and deceptive insurance practices.
[^22]: Barrows opinion (note 4), pp. 25 to 26. The fourth count was brought under N.C. Gen. Stat. § 75-1.1.
[^23]: Lokken opinion (note 1), p. 19.
[^24]: Discovery order (note 6), p. 2, quoting a 2025 order in the case (Doc. 104).
[^25]: Barrows opinion (note 4), pp. 18 to 23.
[^26]: Barrows opinion (note 4), pp. 23 to 24 and 26 (Conclusion). One summary sentence on p. 25 calls the unjust enrichment claim preempted; the analysis before it and the Conclusion let the claim proceed.
[^27]: Barrows opinion (note 4), pp. 12 to 13 and 24.
[^28]: Kisting-Leung order (note 7), pp. 13 to 14. Plaintiffs' Notice of Intent Not to Amend Complaint (E.D. Cal. Apr. 11, 2025), Doc. 56, p. 2: https://litigationtracker.law.georgetown.edu/wp-content/uploads/2023/08/Kisting-Leung_2025.04.11_NOTICE-OF-INTENT-NOT-TO-AMEND-COMPLAINT.pdf
[^29]: Kisting-Leung order (note 7), pp. 15 to 19. The claim is under 29 U.S.C. § 1132(a)(3); under the deferential standard, the court found the reading an abuse of discretion (p. 15). The injunction is discussed at p. 17 and its difference from payment of benefits at p. 19.
[^30]: Kisting-Leung order (note 7), pp. 22 to 25, applying ERISA's preemption provision, 29 U.S.C. § 1144, and its savings clause, § 1144(b)(2)(A).
[^31]: Kisting-Leung order (note 7), pp. 21 to 26. The claim survived for plaintiffs Dababneh and Abbas. Abbas later left the case by stipulation (minute order of August 13, 2026): https://litigationtracker.law.georgetown.edu/wp-content/uploads/2026/08/Kisting-Leung_2026.08.13_ORDER-OF-DISMISSAL.pdf. Cigna did not argue complete preemption, and the court did not consider it.
[^32]: Kisting-Leung order (note 7), pp. 5 to 8, on the declaration of Dr. Kessel (Doc. No. 46-14). The three were plaintiffs Kisting-Leung, Thornhill and Bredlow. Notice of intent not to amend: note 28.
[^33]: Huskey opinion (note 8), pp. 10 to 12.
[^34]: Huskey opinion (note 8), pp. 15 to 17. The court noted that nothing indicates whether the survey controlled for factors other than race, and declined to infer a flaw from that silence (p. 16 n.2).
[^35]: Huskey opinion (note 8), p. 23.
[^36]: Huskey opinion (note 8), pp. 10, 14 and 17 to 24, dismissing the § 3604(a) and § 3605 claims without prejudice. State Farm may raise the McCarran-Ferguson defense again if discovery shows that its liability depends on the actuarial soundness of its claims handling in a way that interferes with Illinois insurance regulation (p. 23).
[^37]: Discovery order (note 6), pp. 2 and 8.
[^38]: Discovery order (note 6), pp. 8 to 13. The order also reached the identities of the board's members. Requests for internal investigations of other algorithms or AI tools were denied.
[^39]: Discovery order (note 6), p. 8.
[^40]: Discovery order (note 6), pp. 5 and 10 to 11. In deciding which documents, and which years, were relevant, the order cited as such an investigation "Refusal of Recovery: How Medicare Advantage Insurers Have Denied Patients Access to Post-Acute Care," Majority Staff Report, U.S. Senate Permanent Subcommittee on Investigations, October 17, 2024, a staff report and not a court finding: https://www.hsgac.senate.gov/wp-content/uploads/2024.10.17-PSI-Majority-Staff-Report-on-Medicare-Advantage.pdf
[^41]: Discovery order (note 6), pp. 8 to 9.
[^42]: Plaintiffs' Motion for Class Certification, *Barrows* (W.D. Ky. Nov. 5, 2026), Doc. 172. "Certain plans" are those whose Evidence of Coverage included its Financial Incentives, Medical Necessity and Coverage Methodology provisions and that delegated post-acute care claims review to naviHealth: https://litigationtracker.law.georgetown.edu/wp-content/uploads/2026/11/Barrows_2026.11.05_PLAINTIFFS-MOTION-TO-CERTIFY-CLASS.pdf
[^43]: Order, *Barrows* (W.D. Ky. Oct. 15, 2026), DN 155: https://litigationtracker.law.georgetown.edu/wp-content/uploads/2023/12/Barrows_2026.10.15_SCHEDULING-ORDER.pdf. Order Granting Joint Motion to Amend Scheduling Order, *Lokken* (D. Minn. Sept. 18, 2026), Doc. 211: https://litigationtracker.law.georgetown.edu/wp-content/uploads/2023/11/Estate-of-Gene-B.-Lokken-The-et-al-v.-UnitedHealth-Group-Inc.-et-al_2026.09.18_SCHEDULING-ORDER.pdf. Kisting-Leung class motion (note 44). Huskey docket, N.D. Ill. No. 1:22-cv-07014, CourtListener copy with entries through November 13, 2026: https://www.courtlistener.com/docket/66635423/huskey-v-state-farm-fire-casualty-company/
[^44]: Lokken order (note 43), pp. 2 to 3; the schedule can be amended again. Barrows class motion (note 42); Barrows order (note 43), pp. 2 to 4. Plaintiffs' Motion for Class Certification, *Kisting-Leung* (E.D. Cal. Oct. 30, 2026), Doc. 111, notice of motion, pp. 1 to 2: https://litigationtracker.law.georgetown.edu/wp-content/uploads/2026/11/Kisting-Leung_2026.10.30_PLAINTIFFS-MOTION-TO-CERTIFY-CLASS.pdf
[^45]: Huskey docket (note 43), including discovery motions and a plaintiffs' motion to amend the complaint filed June 5, 2026.
[^46]: Plaintiffs' Motion for Leave to File Second Amended Class Action Complaint, *Barrows* (W.D. Ky. Sept. 29, 2026), Doc. 143: https://litigationtracker.law.georgetown.edu/wp-content/uploads/2023/12/Barrows_2026.09.29_PLAINTIFFS-MOTION-FOR-LEAVE-TO-AMEND.pdf. The October 15, 2026 order (note 43), pp. 2 to 4, makes no prediction about when the court will rule.
[^47]: Also undecided: Both Medicare Advantage insurers added a defense under the federal filed-rate doctrine to their answers in 2026, and no court has ruled on it. *Lokken*: Defendants' Motion to Amend (Aug. 10, 2026), Doc. 188, https://litigationtracker.law.georgetown.edu/wp-content/uploads/2023/11/Estate-of-Gene-B.-Lokken_2026.08.10_DEFENDANTS-MOTION-TO-AMEND.pdf, granted by minute entry on September 1, 2026, https://litigationtracker.law.georgetown.edu/wp-content/uploads/2023/11/Estate-of-Gene-B.-Lokken-et-al.-v.-UnitedHealth-Group-Inc.-et-al_2026.09.01_SCHEDULING-ORDER.pdf. *Barrows*: Agreed Order accepting the amended answer (Aug. 25, 2026), ECF 138, https://litigationtracker.law.georgetown.edu/wp-content/uploads/2023/12/Barrows-et-al-v.-Humana-Inc_2026.08.26_ORDER.pdf, and the October 15, 2026 order (note 43), p. 1.